9,426
Views
641
CrossRef citations to date
0
Altmetric
Original

Clinical applications of magnetic nanoparticles for hyperthermia

&
Pages 467-474 | Received 19 Dec 2007, Accepted 04 Apr 2008, Published online: 09 Jul 2009

Figures & data

Figure 1. Thermotherapy treatment of the pelvic region after intratumoral injection of magnetic nanoparticles using the alternating magnetic field applicator MFH 300F® (MagForce Nanotechnologies AG, Berlin, Germany).

Figure 1. Thermotherapy treatment of the pelvic region after intratumoral injection of magnetic nanoparticles using the alternating magnetic field applicator MFH 300F® (MagForce Nanotechnologies AG, Berlin, Germany).

Figure 2. Postoperative CT scan of a glioblastoma patient showing magnetic nanoparticles deposits as hyperdense areas within the tumor tissue (left hand). Isothermal lines indicate calculated intratumoral temperatures for a magnetic field strength of 8.0 kA/m corresponding to an SAR of 718 W/kg (derived from the Hounsfield units in the CT scan). The brown line (right hand) represents the tumor area identified by preoperative MRI as fused with the CT scan.

Figure 2. Postoperative CT scan of a glioblastoma patient showing magnetic nanoparticles deposits as hyperdense areas within the tumor tissue (left hand). Isothermal lines indicate calculated intratumoral temperatures for a magnetic field strength of 8.0 kA/m corresponding to an SAR of 718 W/kg (derived from the Hounsfield units in the CT scan). The brown line (right hand) represents the tumor area identified by preoperative MRI as fused with the CT scan.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.